ProductDescription
TMC207(Bedaquiline)isadiarylquinoline-basedinhibitorofbacterialATPsynthaseatnanomolarconcentrations.InvitromycobacterialexperimentsshowthatTMC207inhibitsdrug-sensitiveanddrug-resistantmycobacterialTBatanMICrangeof2to60nMandanMIC50of30ng/mL.AdditionallyTMC207isbroadlypotentagainstmanynon-tuberculousmycobacteria,withMICsof6to500nM.(1)
StudiesshowthatTMC207isorally-availableandefficaciousonaonce-dailyadmiNISTrationforpatientswithpulmonaryTB.Noseriousadverseeventswereobserved.(2)
Technicalinformation:
ChemicalFormula: | C32H31BrN2O2 | |
CAS#: | 843663-66-1 | |
MolecularWeight: | 555.5 | |
Purity: | >98% | |
Appearance: | white | |
ChemicalName: | (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol | |
Solubility: | Upto2mMinDMSO | |
Synonyms: | TMC207,TMC-207,Bedaquiline |
ShippingCondition:Theproductisshippedinaglassvialatambienttemperature.
Storagecondition:Forlongershelflife,storesolidpowderat4oCdesiccated,orstoreDMSOsolutionat-20oC.
Reference:
1. | Matteellietal.,TMC207:thefirstcompoudnofanewclassofpotentanti-tuberculosisdrugs.FutureMicrobiol.2010,5(6),849-858.PubmedID:20521931 |
2. | Rustomjeeetal.,EarlyBactericidalActivityandPharmacokineticsoftheDiarylquinolineTMC207inTreatmentofPulmonaryTuberculosis.Antimicrob.AgentsChemother.2008,52(8),2831-2835.PubmedID:18505852 |
Cellagen的ChamQ SYBR qPCR预混液(无ROX)| Q321产品描述ChamQSYBR®qPCR预混液(Vazyme,#Q321)由香槟Taq DNA聚合酶(Vazyme,#P122)通过抗体修饰的热启动激活技术保护,是专为基于SYBR Green I的定量PCR(qPCR)设计的。ChamQSYBR®qPCR Master Mix的优化缓冲液系统中的独特因素(即促进特异性的Exactor)大大提高了其灵敏度和特异性。该混合物以2倍反应浓度制备,可直接用于鲁棒性低模板qPCR,具有高灵敏度,特异性和可靠性。优点特异性+敏感性的最佳组合。独特的抗体修饰的热启动taq,具有独特的特异性促进因子。Mg2 +和染料的最佳浓度。